There are very few decisions on the statutory predecessors of s.163(1) of the Act. The two principal decisions are General Steel Industries (per Barwick CJ) and Pfizer Corporation v. Ministry of Health [1965] AC 512 (in the House of Lords on appeal from the Court of Appeal). The Crown use provisions of the Copyright Act 1968 (Cth) fell for consideration in Re Australasian Performing Rights Association Ltd's Reference; Re Australian Broadcasting Corporation (1982) 45 ALR 153 by a Full Court of the this court (Bowen CJ, Franki and Sheppard JJ) but the meaning of "for the services of" ultimately did not fall to be and expressly was not decided.
In Pfizer Corporation the House of Lords had occasion to consider s.46(1) of the Patents Act 1949 (UK) which was in the following terms :-
"46.(1)Notwithstanding anything in this Act, any Government department and any person authorised in writing by a Government department may make use and exercise any patented invention for the services of the Crown in accordance with the following provisions of this section."
Pfizer Corporation was the patentee in the UK for the antibiotic drug tetracycline. The drug was used in the National Health Services. In 1961 the Minister of Health invited tenders for the supply of tetracycline from various firms and offered protection to the tenderers relying on s.46 of the Patents Act 1949 (UK). The successful tenderer imported the drug from Italy where it was legally produced by a supplier without the plaintiff's authority. Pfizer Corporation sought declarations that the Ministry of Health had no power under s.46 of the UK Act to authorise this method of supply.
The Ministry of Health was a government department within the meaning
of the section and gave the successful tenderer written authority. The Ministry supplied the drug to National Health Hospitals for administration to both in-patients and out-patients and the main question in the case was whether this use of the drug was "for the services of the Crown".
A majority of the House of Lords (Lord Reid, Lord Evershed and Lord Upjohn) held that the use made of the patented drug was "for the services of the Crown" within the meaning of s.46(1) of the Patents Act 1949 (UK). Both the Court of Appeal and the majority in the House of Lords held that an act was done "for the services of the Crown" if it was done for the purpose of performing a duty or exercising a power which was imposed upon or invested in the executive government by statute or by prerogative.
Lord Wilberforce, in whose judgment Lord Pearce agreed, thought such a definition of the powers of the Crown to use or authorise the use of patented inventions was alarmingly wide. The result of accepting the Ministry's argument (and the formulation of the majority) was, in Lord Wilberforce's view (at 568) :-
"... to withdraw from the benefit of the patent either a large or preponderant part of the customers to supply whom the invention was made (and supposedly protected by a monopoly of the right to vend) - customers being members of the general public, themselves in no way part of a Government department or of a Crown service. To accept this seems to me to go far beyond such a logical extension of the Crown's rights as a liberal process of judicial interpretation may properly accept: it gives to those rights another dimension altogether which it is the province of the legislature to define on a fresh consideration of the respective interests of the public and of the inventor."
The phrase "for the services of the State" was considered in General Steel
Industries. Barwick CJ said (at 133-134) :-
"The evident purpose of s.125, having regard to sub-s. (7), is to ensure that the Governments of the commonwealth and of the States have the invention available to them for the benefit of the services of the respective Governments at once, rather than at the end of the term of the letters patent. Under s.132 the Patents Act recognizes that in Australia those services are managed or performed, not exclusively by departments of government, but as well by `authorities' of the Commonwealth or State. Cf. Patents Act, 1949 (U.K.), s.46 Sub-section (8) of s.125, in providing that no action for infringement shall be brought for what would otherwise be an infringement of the letters patent, emphasizes the clear intention of sub-s. (1) and with sub-s. (7) provides a means of securing the untrammelled use of the invention by the Governments and the authorities of the Commonwealth and of the States. On the other hand, sub-ss (5) and (6) ensure that proper compensation shall be paid to the owner of the letters patent for the acts of a Government or an authority of Commonwealth or State which makes use of the invention.
The railway system of the State is, in my opinion, undoubtedly a service of the State and the use of the invention in the construction of railway carriages to be used by the Commissioner in that railway system is a use for a service of the State or for the services of the State within the meaning of the expression in the Patents Act 1952, whichever may be the proper way to read the final words of s.125(1). One could scarcely imagine that sections such as ss.125 and 132, with their evident practical purpose, did not extend to include within the expression the use of the services of the Commonwealth or State, the use of an invention for the purposes of one of the Government railway systems in Australia.
In the case of the Commissioner, therefore, there are present not merely the circumstances to which I have already called attention, but the asset of the State which is under his control and management, subject to Ministerial direction, is itself for relevant purposes a service of the State.
All these factors combine, in my opinion, to require the answer that the Commissioner is an authority of the State within the meaning of ss.125 and 132 of the Patents Act. I am also of opinion that the use by the Commissioner - if his contracting with the other defendants in the circumstances amounts to a use of the invention by him, as indeed the plaintiff claims - is a use for the services or for a service of the State, within the meaning of those sections."
There is nothing in the authorised report of General Steel Industries to indicate whether Barwick CJ was referred to the decision in Pfizer Corporation at first
instance or before the English Court of Appeal. The House of Lords' decision was given in February 1965 after the decision in General Steel Industries. However Barwick CJ did have regard to the decisions in Pyrene Company Limited v. Webb Lamp Company Ltd. (1920) 37 RPC 57 and Aktiengesellschaft Fur Autogene Aluminium Schweissung v. London Aluminium Co. Ltd. [No. 2] (1923) 40 RPC 107.
In Pyrene Company Ltd. v. Webb Lamp Company Ltd., the Ministry of Munitions contracted with the defendant to supply fire extinguishers which infringed the plaintiff's patent. The evidence established that the defendant was shown an extinguisher of the plaintiff's manufacture and directed by the Ministry to reproduce it. The defendant manufacturer was sued for infringement, the alleged infringement being sale of the reproduced extinguishers to the Ministry. The contracts were entered into during the period of hostilities in the First World War. The defendant claimed the protection of s.29 of the Patents and Designs Act 1907 (UK) which provided :-
"A patent shall have to all intents the like effect as against His Majesty the King, as it has against a subject, provided that any Government Department may by themselves, their agents, contractors, or others, at any time after the application, use the invention for the services of the Crown on such terms as may, either before or after the use thereof, be agreed on, with the approval of the Treasury, between the Department and the patentee, or, in default of agreement, as may be settled by the Treasury after hearing all parties interested."
Lawrence J held (at 65-66 ) :-
"It is not to be wondered at that contracts entered into at the time when this contract was entered into were possibly not of the best draughtmanship. It was a time of stress and trouble in the country. Printed forms were used by the Ministry of Munitions. Everybody was in a rush and under a strain which was almost at breaking point just at this time. There were shipping difficulties and other difficulties had to be considered. The tender and the acceptance in these cases I have seen and they are on the usual printed
forms, and I hold that, notwithstanding the particular wording of this contract, it was a contract which compelled the Defendants to copy as closely as they could the Plaintiffs' patented invention. I further come to the conclusion that it was the intention that the Defendants were not bound to obtain the leave of the Plaintiffs to make their machine, and that one of the reasons for entering into this contract was that the Plaintiffs not only were asking too much for their extinguisher in the opinion of the Ministry of Munitions, but also were importing parts or the whole machine - I am not sure which - from America, and it was desired to conserve the shipping.
In these circumstances I hold that this agreement was one which, within the exception admitted by Mr. Hunter Gray, compelled the manufacture of this particular machine without obtaining the leave or licence of the Patentee. In those circumstances, without expressing my opinion as to the larger question, I unhesitatingly hold that the Defendants were contractors within the meaning of Section 29, and that the Plaintiffs' invention was being used by a Government Department, namely, the Ministry of Munitions, by their contractors, the Defendants, for the services of the Crown. That being so, I am of opinion that Section 29 forms a good defence to this action, and that the Defendants, as contractors, are immune from any proceedings for an injunction or for damages."
In Aktiengesellschaft fur Autogene Aluminium Schweissung v. London Aluminium Co. Ltd. [No. 2], the plaintiff was the patentee of two patents relating to the welding of aluminium. The defendant had, inter alia, supplied welded articles for use by the Government. The issue was whether s.29 of the 1907 UK Act provided a defence to the defendant. The evidence established that in some cases the defendant did the welding itself, in others it sub-contracted the work. Sargant J said (at 117) :-
"... In my judgment, the Section is primarily an agency section, that is to say, protection is afforded to the Government department, and to any person or persons, contractors or others, who are acting as agents for, or by the express or implied authority of, a Government department. In each case, it will have to be ascertained, if the parties think fit to fight out each individual case, whether the acts of the Defendant Company in that particular case were acts done for the purposes of the Crown, and with the authority, or by the direction, of the Crown. In that case, they will not be liable; but where the acts that they have done have not been done by virtue of some express or implied authority from the Crown, then it seems to me they will be liable. It may be in many cases that, where they are sub-contractors, there will have been such a relation between them and their
contractors, such a direction given by the Government to the contractors, or such a direct supervision over the employers by the Government, as will amount to an implied authority sufficient to make the Company in that individual case an agent acting by the authority, and for the purposes, of the Crown."
In the reasoning of Lord Wilberforce in Pfizer Corporation it was the re-supply by the government department in competition to the patentee which underpinned the conclusion that the grant of monopoly rights was not by the exception in s.46(1) of the Patents Act 1949 (UK) to derogate from the monopoly to a greater extent than the right of the Crown to exploit the invention for its own immediate purposes. (See [1965] AC at 568).
In each of the three first instance cases there was the supply of an item by a contractor for the direct use of the authority of a State (in the case of General Steel Industries) or the government department (in the case of the UK cases). In no case was the item re-supplied by the State or department to a third party in competition to the patentee where that third party was a prospective customer of the patentee. Factually each of these three cases falls within the majority and minority views in Pfizer Corporation.
The law in this country is no narrower than the minority view in that decision. If the facts in the instant case fall within the minority view in Pfizer Corporation and the first instance cases referred to above, it is unnecessary for present purposes to determine whether the majority view in Pfizer Corporation is the law of Australia.